Mutual of America Capital Management LLC Has $6.29 Million Stock Position in Addus HomeCare Co. (NASDAQ:ADUS)

Mutual of America Capital Management LLC lessened its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 7.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 60,833 shares of the company’s stock after selling 4,797 shares during the quarter. Mutual of America Capital Management LLC owned approximately 0.37% of Addus HomeCare worth $6,286,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in ADUS. Principal Securities Inc. acquired a new stake in Addus HomeCare in the fourth quarter valued at $26,000. GAMMA Investing LLC bought a new position in Addus HomeCare during the fourth quarter worth about $34,000. Assetmark Inc. grew its holdings in Addus HomeCare by 33.3% during the fourth quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock worth $165,000 after purchasing an additional 443 shares during the period. Envestnet Portfolio Solutions Inc. acquired a new position in Addus HomeCare during the fourth quarter worth approximately $214,000. Finally, Cetera Trust Company N.A bought a new stake in Addus HomeCare in the fourth quarter valued at approximately $219,000. 95.35% of the stock is owned by institutional investors.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 217 shares of the company’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $116.13, for a total transaction of $25,200.21. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,186,500.21. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Price Performance

ADUS stock traded down $1.05 during midday trading on Tuesday, reaching $117.79. The company had a trading volume of 67,441 shares, compared to its average volume of 132,585. The company has a market capitalization of $2.13 billion, a price-to-earnings ratio of 29.34, a price-to-earnings-growth ratio of 2.27 and a beta of 1.01. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.35 and a quick ratio of 1.35. Addus HomeCare Co. has a 1-year low of $78.35 and a 1-year high of $120.53. The stock has a 50 day moving average price of $112.50 and a 200-day moving average price of $100.92.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, May 6th. The company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The company had revenue of $280.70 million during the quarter, compared to the consensus estimate of $279.49 million. During the same quarter in the prior year, the firm posted $0.84 EPS. The firm’s quarterly revenue was up 11.6% on a year-over-year basis. Equities research analysts expect that Addus HomeCare Co. will post 4.36 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on ADUS shares. Macquarie assumed coverage on Addus HomeCare in a research note on Friday, June 28th. They set an “outperform” rating and a $136.00 target price for the company. Stephens increased their price target on shares of Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a report on Friday, May 31st. StockNews.com cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday. Bank of America increased their target price on Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a research note on Tuesday, May 7th. Finally, Barclays downgraded Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target for the company. in a research note on Tuesday, April 23rd. One equities research analyst has rated the stock with a sell rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average price target of $116.25.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.